维普中文期刊产品整合服务
1630篇 您的检索式:作者名="BERGER P"
    题名 作者 年代 出处 被引量
1rate of adverse events of gastroduodenal snare polypectomy for non-flat polyp is low: A prospective and multicenter study显示文摘AIM To evaluate the rate of adverse events(AEs) during consecutive gastric and duodenal polypectomies in several Spanish centers. METHODS Polypectomies of protruded gastric or duodenal polyps ≥ 5 mm using hot snare were prospectively included. Prophylactic measures of hemorrhage were allowed in predefined cases. AEs were defined and graded according to the lexicon recommended by the American Society for Gastrointestinal Endoscopy. Patients were followed for 48 h, one week and 1 mo after theprocedure. RESULTS308 patients were included and a single polypectomy was performed in 205. Only 36(11.7%) were on prior anticoagulant therapy. Mean polyp size was 15 ± 8.9 mm(5-60) and in 294 cases(95.4%) were located in the stomach. Hemorrhage prophylaxis was performed in 219(71.1%) patients. Nine patients presented AEs(2.9%), and 6 of them were bleeding(n = 6, 1.9%)(in 5 out of 6 AE, different types of endoscopic treatment were performed). Other 24 hemorrhagic episodes could be managed without any change in the outcome of the endoscopy and, consequently, were considered incidents. We did not find any independent risk factor of bleeding.CONCLUSION Gastroduodenal polypectomy using prophylactic measures has a rate of AEs small enough to consider this procedure a safe and effective method for polyp resection independently of the polyp size and location.Henry Córdova Lidia Argüello Carme Loras Antonio Naranjo Rodríguez Faust Riu Pons Joan B Gornals David Nicolás-Pérez Xavier Andújar Murcia Luis Hernández Santos Santolaria Carles Leal Carles Pons Enrique Pérez-Cuadrado-Robles Orlando García-Bosch Michel Papo Berger José Luis Ulla Rocha Cristina Sánchez-Montes Gloria Fernández-Esparrach 2017World Journal of Gastroenterology2017,23,47:3
2Investors valuation of the abandonment options显示文摘Berger P G Ofek Swary I 1996Journal of Financia Economics1996,42,2:2
3Antithrombotic therapy dur ing percutaneous coronary intervention: the Seventh ACCP Conference on Antithromhotic and Thrombolytic Therapy显示文摘Popma JJ Berger P Ohman EM 2004Chest2004,126,3:1
4Shadowgraph- ic and interferometric investigations on Nd:YAG laser-induced vapor/ plasma plumes for different processing wavelengths 显示文摘BREITLING D SCHITTENHELM H BERGER P 1999Appl Phys1999,69,1:1
5Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunction显示文摘Berger A P Deibl M Leonhartsberger N 2005BJU Int2005,96,7:1
6Diversification' s effect on firm value 显示文摘Berger P G Ofek E 1995Journal of Financial Economics1995,37,1:1
7Establishment, val- ue assignment and characterization of new WHO reference reagents for six molecular forms of human chorionic gonado- trophin显示文摘A Bristow P Berger J Bidart 2005ClinChem2005,51,1:1
8Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-anal- ysis 显示文摘Chu S G Becker R C Berger P B 2010J Thromb Haemost2010,8,1:1
9Induction of glioma cell death by 1, 25 (OH) 2 vitamin I)3: Towards an endocrine therapy of brain tumors? 显示文摘Naveilhan P Berger F Haddad K 1994J Neurosei Res1994,37,2:1
10Applying the Analytic Hierarchy Process to the Offshore Outsourcing Location Decision显示文摘Liu B L Berger P Zeng A 0,,:1
11Molecular cell biology of Charcot-Marie-Tooth disease显示文摘 Young P Suter U 2002Neu Rogenetics2002,4,1:1
12Analysis of lesion development during acute inflammation and remission in a rat model of experimental autoimmune encephalomyelitis by visualization of macrophage infiltration, demyelination and blood-brain barrier damage显示文摘Berger C Hiestand P Kindler-Baumann D 2006NMR Biomed2006,19,1:1
13Atherosclerosis as a risk factor for benign prostatic heperplais显示文摘Berger A P Bartsch G Deibl M 2006BJU Int2006,98,5:1
14Explicit and implicit effects of the R&D tax credit显示文摘Berger P G 1993Journal of Accounting Research1993,,31:1
15Identification of inflicted traumatic brain injury in well-appearing infants using serum and cerebrospinalmarkers:A possible screening tool显示文摘Berger R P Dulani T Adelson P D 2006Pediatrics2006,117,2:1
16From customer lifetime value to shareholder value:Theory,empirical evidence,and issues for future re-search显示文摘Berger P D 2006Journal of Service Research2006,9,2:1
17Antimyelin antibodyies as apredictor of clinically definite multiple sdlerosis after afirst demyelinating event显示文摘Berger T Rubner P Schautzer F 2008J N Engl J Med Boston2008,349,2:1
18Detection of pictogramquantities of potyviruses using a dot immunobinding assay 显示文摘Berger P H Thornbury D W Pirone T P 1985J Virol Methods1985,12,:1
19Transcatheter closure of atrial septal defects without fluoroscopy: Feasibility of a new method显示文摘Ewert P Berger F Daehner I 2000Circulation2000,101,:1
20Wath is the role improved long-term antiplatelet therapy after precutaneous coronary intervention? 显示文摘Steinhubl S Berger P 2003Am Heart J2003,145,6:1
返回顶部 每页显示:
共82页 首页 上一页 第1页 下一页 末页 /82 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费